Latest Information Update: 22 Nov 2007
At a glance
- Originator Terumo
- Mechanism of Action Ras gene inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 22 Nov 2007 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 07 Apr 2003 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 12 Jan 2000 Preclinical development for Cancer in Japan (Unknown route)